| Tissue microarrays for high-throughput molecular profiling of tumor specimens J Kononen, L Bubendorf, A Kallionimeni, M Bärlund, P Schraml, ... Nature medicine 4 (7), 844-847, 1998 | 5610 | 1998 |
| Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients L Bubendorf, A Schöpfer, U Wagner, G Sauter, H Moch, N Willi, ... Human pathology 31 (5), 578-583, 2000 | 2231 | 2000 |
| Gene-expression profiles in hereditary breast cancer I Hedenfalk, D Duggan, Y Chen, M Radmacher, M Bittner, R Simon, ... New England Journal of Medicine 344 (8), 539-548, 2001 | 2154 | 2001 |
| Survey of gene amplifications during prostate cancer progression by high-throughput fluorescence in situ hybridization on tissue microarrays L Bubendorf, J Kononen, P Koivisto, P Schraml, H Moch, TC Gasser, ... Cancer research 59 (4), 803-806, 1999 | 890 | 1999 |
| PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ... Journal of Thoracic Oncology 13 (9), 1302-1311, 2018 | 684 | 2018 |
| Tissue microarrays for gene amplification surveys in many different tumor types P Schraml, J Kononen, L Bubendorf, H Moch, H Bissig, A Nocito, ... Clinical Cancer Research 5 (8), 1966-1975, 1999 | 681 | 1999 |
| High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma H Moch, P Schraml, L Bubendorf, M Mirlacher, J Kononen, T Gasser, ... The American journal of pathology 154 (4), 981-986, 1999 | 618 | 1999 |
| 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up J Vansteenkiste, L Crino, C Dooms, JY Douillard, C Faivre-Finn, E Lim, ... Annals of Oncology 25 (8), 1462-1474, 2014 | 536 | 2014 |
| Tissue microarray (TMA) technology: miniaturized pathology archives for high‐throughput in situ studies L Bubendorf, A Nocito, H Moch, G Sauter The Journal of pathology 195 (1), 72-79, 2001 | 535 | 2001 |
| Loss of NKX3. 1 expression in human prostate cancers correlates with tumor progression1, 2 C Bowen, L Bubendorf, HJ Voeller, R Slack, N Willi, G Sauter, TC Gasser, ... Cancer research 60 (21), 6111-6115, 2000 | 534 | 2000 |
| Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays L Bubendorf, M Kolmer, J Kononen, P Koivisto, S Mousses, Y Chen, ... Journal of the National Cancer Institute 91 (20), 1758-1764, 1999 | 492 | 1999 |
| Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers P Went, M Vasei, L Bubendorf, L Terracciano, L Tornillo, U Riede, ... British journal of cancer 94 (1), 128-135, 2006 | 468 | 2006 |
| Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis M Bärlund, F Forozan, J Kononen, L Bubendorf, Y Chen, ML Bittner, ... Journal of the National Cancer Institute 92 (15), 1252-1259, 2000 | 410 | 2000 |
| 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer WEE Eberhardt, D De Ruysscher, W Weder, C Le Pechoux, P De Leyn, ... Annals of Oncology 26 (8), 1573-1588, 2015 | 402 | 2015 |
| Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade A Nocito, L Bubendorf, EM Tinner, K Süess, U Wagner, T Forster, ... The Journal of pathology 194 (3), 349-357, 2001 | 394 | 2001 |
| Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer R Simon, A Nocito, T Hübscher, C Bucher, J Torhorst, P Schraml, ... Journal of the National Cancer Institute 93 (15), 1141-1146, 2001 | 364 | 2001 |
| Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer KM Kerr, L Bubendorf, MJ Edelman, A Marchetti, T Mok, S Novello, ... Annals of Oncology 25 (9), 1681-1690, 2014 | 360 | 2014 |
| Elevated expression of inhibitor of apoptosis proteins in prostate cancer M Krajewska, S Krajewski, S Banares, X Huang, B Turner, L Bubendorf, ... Clinical cancer research 9 (13), 4914-4925, 2003 | 356 | 2003 |
| Stat3 promotes metastatic progression of prostate cancer J Abdulghani, L Gu, A Dagvadorj, J Lutz, B Leiby, G Bonuccelli, ... The American journal of pathology 172 (6), 1717-1728, 2008 | 313 | 2008 |
| Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings L Bubendorf, B Grilli, G Sauter, MJ Mihatsch, TC Gasser, P Dalquen American journal of clinical pathology 116 (1), 79-86, 2001 | 311 | 2001 |
